A systematic evaluation of the dosing regimens for approved targeted therapies and immune checkpoint inhibitors in metastatic renal cell carcinoma from a project OPTIMUS perspective

Author(s):
Tan, Z.; Völler, S. (0000-0003-0587-2775); Sancho‐Araiz, A.; Knibbe, C.A.J. (0000-0001-9893-4415); Moes, D.J.A.R.
Published
2025
Publication type
Article / Letter to editor
Date issued
2025-05-02
Language
English
Publisher
Wiley
Is part of
The Journal of Clinical Pharmacology (2025), Vol. 65, no. 10, p. 1187-1207
hdl
1887/4248390
doi
10.1002/jcph.70035